As a result, the levels of IL-18 and IL-1β were significantly reduced, and the protein expressions of NLRP3, gasdermin D, caspase 1, and ASC were also significantly decreased after PSG treatment, suggesting the good suppression of PSG on pyroptosis in treating SLI of the IBD mouse model. This evidence concerns the gene NLRP3 and inflammatory bowel disease.